The Top 6 Best Analyst Coverage on Intercept Pharmaceutical Inc

By Cody Miecnikowski Intercept Pharmaceutical Inc (NASDAQ:ICPT), a clinical stage bio-pharmaceutical company focused on the development and commercialization of novel therapeutics to treat underserved liver diseases, is set to report second quarter 2015 earnings after market close on August 5. Wall Street analysts have been weighing in on ICPT throughout the year as the biopharmaceutical … Read more